Follicular wave status at the beginning of the FSH treatment modifies reproductive features in superovulated sheep.
In the current study we investigated whether the developmental status of the two largest follicles (LF1 and LF2) at the time of administration of the first two doses (0 and 12 h) of FSH of a superovulatory treatment influences periovulatory events and embryo yields in sheep. A larger size of LF1 was negatively correlated with embryo recovery (r=-0.608 for 0 h and r=-523 for 12 h, p<0.05), fertilization (r=-0.464 for 12 h, p<0.05) and viability (r=-0.775 for 12 h, p<0.005). Embryo viability rates were also lower when a higher difference between LF1 and LF2 (r=-0.839 for 0 h and r=-0.761 for 12 h, p<0.01) and a smaller size of LF2 (r=0.877 for 0 h and r=0.622 for 12 h, p<0.01) were observed. This indicates the existence of a limit in the follicular size that will be able to give rise a viable embryo. Conversely, a larger size of LF2 at the time of administration of the first two FSH doses was correlated with reduced recovery rates (r=-0.884 for 0 h and r=-0.706 for 12 h, p<0.01), whilst a decreasing size of LF1 and LF2 was correlated with an increased ovulation rate and recovered embryos. The dominance effect appeared to affect the timing of the preovulatory LH surge. Ewes with a higher difference between LF1 and LF2 displayed earlier LH surges (r=-0.420 for 0 h and r=-0.401 for 12 h, p<0.05) which were related to a higher number of non viable embryos (r=-0.777, p<0.05). The fact that superovulatory yields were affected by, both LF1 and LF2 supports the hypothesis of co-dominance effects in sheep.
Veiga-Lopez
Almudena
A
Departamento Reproducción Animal INIA, Avda. Puerta de Hierro s/n, 28040, Madrid, Spain. vlopez@inia.es
Cocero
Maria J
MJ
Dominguez
Veronica
V
McNeilly
Alan S
AS
Gonzalez-Bulnes
Antonio
A
D000818:Animals; D003008:Cloprostenol / Q000494:pharmacology; D004971:Estrus / Q000187:drug effects; D005260:Female; D005300:Fertility Agents, Female / Q000494:pharmacology; D003425:Flurogestone Acetate / Q000494:pharmacology; D005640:Follicle Stimulating Hormone / Q000494:pharmacology*; D006080:Ovarian Follicle / Q000187:drug effects* / Q000502:physiology*; D012756:Sheep / Q000502:physiology*; D013480:Superovulation / Q000187:drug effects
D005300:Fertility Agents, Female; D003008:Cloprostenol; D005640:Follicle Stimulating Hormone; D003425:Flurogestone Acetate